Boy you are right. If we had a major feature story in the New York Times about how our Long Haulers trial went so well and is now filling up its second half, that would really hurt our chances of approval. Or a NYTimes story on our continuation of CD12 with Brazil, boy that would hurt our chances of getting that trial going and getting approval.

We should be so lucky as to have a major media source notice us.